Traditional III/IV grading classification could be potentially the primary factor for the differences we observed in our patients’ cognitive performance as, consistently with the literature, the majority of grade III gliomas were IDH1-mutant-type ones and the majority of grade IV gliomas were IDH1 wild-type ones. Here, IDH1 is linked to central nervous system cancer.